**Title: The Promise of GLP-1 in Inflammation Therapy** **Date: October 5, 2023** — Key Takeaways GLP-1…
Day: March 17, 2025
Clinical trial challenges in China: How a Sharp and ClinsChain pairing is breaking down barriers
While China has become a key country for global clinical trials, navigating regulatory complexities and ensuring…
Taiho outlays $1.14bn to acquire ADC specialist Araris
Taiho is turning its long-time ADC partner into a wholly owned subsidiary with the acquisition.
GLP-1 Agonists and Kidney Health: What You Need to Know
**Title: The Role of GLP-1 Agonists in Kidney Health: A Comprehensive Overview** **Date: October 5, 2023**…
GLP-1 and Lipid Metabolism: A Comprehensive Overview
**Title: The Emerging Role of GLP-1 in Lipid Metabolism: A Comprehensive Overview** **Glucagon-like peptide-1 (GLP-1) is…
Azurity acquires Covis Pharma from existing investors
Azurity Pharmaceuticals has acquired Covis Group from existing investors, making the latter a wholly owned subsidiary.
The cost of insurance cuts | Morning Newsletter – The Philadelphia Inquirer
The cost of insurance cuts | Morning Newsletter The Philadelphia Inquirer
Kansas, we’re more obese than the national average. These new medications can help | Opinion – Kansas City Star
Kansas, we’re more obese than the national average. These new medications can help | Opinion Kansas City…
Anti-Obesity Drugs Market Industry Trends, Sales Forecast, – GlobeNewswire
Anti-Obesity Drugs Market Industry Trends, Sales Forecast, GlobeNewswire
Anti-Obesity Drugs Market Industry Trends, Sales Forecast, – GlobeNewswire
Anti-Obesity Drugs Market Industry Trends, Sales Forecast, GlobeNewswire